Researchers explore earlier genetic diagnoses, improved cancer diagnostics, and genomic tracking of a deadly mpox outbreak in children. Studies demonstrate the potential to identify inherited conditions years before symptoms appear and improve childhood cancer testing.
A new study published in JNCCN found that comprehensive biomarker testing before treatment for advanced lung cancer was associated with patients living longer. Broad-based genomic sequencing helped identify a wider range of tumor biomarkers, guiding targeted treatment and improving survival outcomes.
Researchers develop AI models to identify and classify blood cancers, achieving 99.5% sensitivity and 90.9% positive predictive value. An open-source platform, Turnkey Precision Oncology, helps molecular pathologists interpret genetic sequencing data and generate clinical reports with high accuracy.
A new tool, Responses to Illness Severity Quantification (RISQ), has been shown to save lives and reduce hospital stays among children with malnutrition in low-resource communities. The study, conducted in Chad, found that RISQ could prevent one child death for every 282 children where health-care workers used the system.
Researchers at the University of Cincinnati found a potential biomarker for PTSD susceptibility in female animal models, suggesting a link to stress hormone patterns. The study suggests that a simple stress provocation test could serve as a clinical biomarker for PTSD risk and point toward early interventions. The findings raise the po...
A new study reveals that the CASS4 gene plays a crucial role in Alzheimer's disease by directing brain-cleaning immune cells, which can be disrupted leading to the buildup of toxic plaques. This discovery offers new hope for the development of treatments or prevention strategies by targeting the gene or microglia in the brain.
Researchers at Hoag Memorial Hospital Presbyterian discovered a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma, an early precancerous stage of ovarian cancer. The breakthrough may enable detection years earlier, transforming ovarian cancer surveillance and prevention.
The National MS Society is launching a funding opportunity to support innovative screening technologies for early MS detection. The goal is to accelerate progress in identifying individuals at risk of MS, ultimately reducing time to diagnosis and improving long-term outcomes.
Researchers developed a non-invasive test to detect chronic inflammation by analyzing extracellular vesicles in blood and urine. They identified specific microRNAs and membrane proteins to distinguish kidney inflammation from other types, providing clues to the source of chronic inflammation.
Since 2010, medical profiles of adults diagnosed with autism have changed significantly, shifting from epilepsy, psychosis, and intellectual disability to ADHD, anxiety, depression, and other mental health conditions. The number of diagnoses has increased, particularly among 16-20 year olds, females, and those of White ethnicity.
Researchers from Shandong University explore how precisely arranged nanoscale building blocks can produce stronger signals and bring different sensing functions together for disease biomarker detection. Structural design strategies are being used to advance the field, including single-component assembly and multicomponent co-assembly.
Researchers have discovered a link between CDK1 protein activity and breast cancer response to CDK4/6 inhibitors. Higher CDK1 activity is associated with more aggressive cancer and poorer outcomes. The study suggests that tracking CDK1 activity could help doctors identify patients most likely to benefit from targeted therapy.
A new study reveals concerns about misdiagnosis and stigma in autoimmune diseases with functional neurological disorder (FND), highlighting the need for better communication and holistic care. Patients and clinicians often see things differently, and poor explanations can lead to feelings of guilt, shame, and suicidal thoughts.
Researchers have developed a blood test that can identify brain injury severity in patients, helping clinicians escalate care. The test uses two proteins, GFAP and UCH-L1, which rise in the bloodstream after injury, and can differentiate between patients with acute brain injury and those with no evidence of pathology.
A new study links 12 blood proteins to prostate cancer diagnosed over 15 years after blood sampling, including immune cells and cancer driver genes. The research may help identify men at greater risk of aggressive prostate cancer and inform future studies.
A new study reveals AI chatbots successfully identify redundant medical interventions in most cases, but stumble in gray areas where human consensus is divided. The study found that AI models often echo human disagreements, and struggle to convey restraint in social interactions with patients.
A consensus statement has been reached on the recognition, diagnosis, and management of traumatic brain injury in first responders. The guidelines emphasize shared organizational responsibility, supportive reporting processes, and occupation-specific return to duty progression to improve recovery outcomes and reduce stigma.
A new UVA study finds that Black children are more likely to develop severe asthma due to harmful inflammation, regardless of environmental factors. The research suggests tailored treatments for Black children with severe symptoms, and testing for high levels of T2 inflammation in all children with difficult-to-treat asthma.
Researchers propose recognizing recompensation as a distinct treatment-related disease state, distinguishing stable and unstable recovery, to better capture recovery and continuing risks after cirrhosis treatment. This framework could support more consistent research, clinical assessment, and long-term surveillance for patients recover...
Artificial intelligence can match human doctors in certain tasks, but human doctors are essential for making complex decisions about patient care. AI may identify a patient's medical condition, but human doctors must consider individual circumstances and make choices that work in the patient's best interest.
A new study led by Professor Paolo Pozzilli examines Botticelli's depictions of Venus' eyes, revealing swelling and tissue changes consistent with a pituitary tumour. The findings support the original hypothesis of a pituitary tumour diagnosis for the model's death.
Researchers have developed a self-healing technology that coats copper wires with a liquid metal alloy, preventing cracks and corrosion. The alloy forms a rugged intermetallic compound that acts as a chemical brake, stopping corrosion and restoring electrical flow.
Researchers propose matching sensing frequency to biomarker type and pairing with contextual data like blink patterns and tear flow to separate true biological change from normal fluctuations. The goal is to design sensors that can trust readings over time, moving beyond just counting biomarkers.
A modified acupuncture needle enables minimally invasive sampling of lymph node-derived DNA for molecular profiling, offering a robust alternative to current clinical liquid biopsy approaches. The novel platform, His@PDA@Needle, is significantly less invasive than conventional lymph node biopsy and intended to complement histopathologi...
A new study published in the Journal of the American College of Radiology found that automated breast ultrasound (ABUS) had similar cancer detection rates to handheld ultrasound (HHUS) in women with dense breasts, while ABUS had a lower false-positive rate. ABUS is a viable alternative to HHUS for supplemental ultrasound screening.
SourceElsevier·JournalJournal of the American College of Radiology·TypeData/statistical analysis·DateOct 8, 2026
A new study reveals molecular features linked to more aggressive prostate cancer in patients classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies and more precise risk stratification.
Researchers found that well-designed digital alerts can assist clinicians in high-pressure situations, prompting them to make recommended treatment decisions and recognize when patients are deteriorating. The studies demonstrated the effectiveness of electronic health record alerts in the emergency department and cardiac intensive care...
Researchers are working on a four-year project to develop a personalized model that uses detailed blood flow information to detect obstructions in the aorta. The project aims to improve prenatal testing so that doctors can spot problems in the aorta before a baby is born and recommend treatments.
Researchers developed a label-free platform combining microfluidic cell sorting with AI to enrich and identify rare CTCs. The integrated strategy uses inertial microfluidic enrichment and YOLOv8-based deep learning for bright-field image recognition, achieving 96.0% accuracy in distinguishing tumor cells.
A blood test that compares two molecules in the blood can accurately distinguish between bacterial and viral infections in newborn babies with fever. The test showed a high sensitivity and specificity, and could potentially improve treatment and reduce unnecessary antibiotic use.
Researchers have developed a laser-powered technology that accelerates antibody-antigen interactions to detect tiny amounts of a colorectal cancer biomarker within minutes. This technology has the potential to improve cancer diagnosis by increasing detection sensitivity and speed.
A new diagnostic test for Alzheimer's disease is being developed using blood-based diagnostics, which could provide a more accurate prognosis and treatment options. The test, led by Lund University, aims to improve early diagnosis and treatment of the disease.
A new DNA test has been developed to identify the genetic causes of inherited muscle disease, offering hope for diagnosis and treatment for thousands of Australians. The test, which uses long-read sequencing, screens over 300 genes and detects complex genetic changes that older tests miss.
Researchers at MIT have developed a handheld device to collect living cells from specific locations in patient samples, enabling early cancer detection and personalized medicine development. The device uses a microfluidic channel to gently detach living cells from tissue, allowing for targeted sampling and cultivation for diagnostics a...
Researchers found that sensory neurons retain a memory of allergens that may explain why allergies develop over time. This memory primes neurons to respond more strongly to later exposures, even after the original allergen is gone.
The AudioSight platform combines smartphone-based pupillometry, low-cost near-infrared hardware, and AI analysis to screen for and track hearing-related disorders. The platform generates risk scores for auditory dysfunctions using a BiLSTM-attention model, offering a potential solution for widespread hearing disorders.
Researchers developed a non-invasive method to detect Meniere's disease using mass spectrometry on earwax samples, providing a rapid and cost-effective solution for diagnosis. The technology offers enhanced diagnostic accuracy and opens new avenues for monitoring disease progression and response to treatment.
A novel multimodal auditory assessment platform combines brain-activity measurements and pupil-response monitoring to evaluate hearing-related disorders. The platform has been implemented for data collection and has shown promise in identifying features associated with abnormal auditory sensitivity.
The new guidelines, developed by leading experts, focus on improving sepsis care by strengthening systems for diagnosis, treatment, prevention, and quality improvement. Emerging technologies, such as next-generation diagnostics and artificial intelligence, are also being explored to enhance sepsis care.
A five-year project led by UC Riverside researcher Erica Heinrich seeks to improve respiratory care for patients with conditions like COPD and those on mechanical ventilation. The study aims to develop a machine-learning algorithm that can predict respiratory comfort more accurately than physicians' estimates.
Researchers at Tulane University have developed a diagnostic platform that can identify the precise species of bacteria causing NTM lung disease infections within four hours. The platform, called CANDI, uses mucus from the lungs and other respiratory fluids to test for up to 15 clinically relevant species and subspecies of NTM bacteria.
This technology combines electrocardiogram signals and electrical impedance tomography data to aid in the diagnosis and treatment of cardiac and pulmonary conditions. The simultaneous acquisition of ECG and EIT data provides precise cardiac timing and enhances EIT image reconstructions.
A new study reanalysed data from eight randomised trials on mammography screening, finding overdiagnosis to be less than 5%. The researchers suggest that previous high estimates of overdiagnosis were based on incomplete evidence and taken out of context.
This DNA nanoswitch technology detects RNases using a simple mix-and-read methodology, offering a cost-effective solution for biological samples. The nanoswitch changes shape in response to RNase presence, making it a useful tool for RNase-sensing applications.
The AI-powered platform, OralScan, uses artificial intelligence and user-captured photographs to identify common dental conditions, enabling longitudinal tracking of oral health findings. The platform targets seven conditions, including dental caries, periodontal disease, and tooth loss, and is available for licensing or collaboration.
A new saliva-based assay rapidly and accurately assesses flavivirus immunity by measuring multiple antibody classes in saliva. The test can distinguish between individuals with polytypic dengue virus immunity and those who have previously experienced both dengue virus and Zika virus infections.
Two studies on the 2026 Bundibugyo virus outbreak highlight new approaches to rapid diagnostics and vaccine preparedness. Diagnostic tests can be evaluated rapidly during an outbreak, and the 2026 virus may offer some cross-protection with existing Ebola vaccines.
Researchers will develop a molecular diagnostic test that quantifies small RNA species to detect fetal oxygen deprivation during labor. The technology aims to provide clinically relevant values for stratifying the risk of babies during labor.
A recent study suggests that cerebral palsy (CP) may be a collection of symptoms that can occur in various conditions, rather than a single disease with genetic causes. The research found that only 89 of 515 genes previously linked to CP have a statistically significant association with the condition.
A scoping review found that only 77 studies validating 52 medical AI products reported demographic data, highlighting the need for more transparent reporting to confirm safe and unbiased performance. The review also showed that performance reporting for demographic subgroups is inadequate, posing a risk to patient care and outcomes.
A new study reveals striking biological similarities between five major illnesses, including long Covid and PTSD, suggesting common underlying mechanisms. Chronic fatigue syndrome, rheumatoid arthritis, and multiple sclerosis may be driven by shared regulatory networks in immune and metabolic systems.
Prostate cancer affects 1 in 8 men, with 60% diagnosed in men 65 and older. Clinical trials like Alliance's help improve early detection and treatment, reducing mortality rates by half since 1993. These trials also explore new treatments and survivorship strategies.
A new study suggests a simple urine test could improve kidney transplant decisions by using donor urinary biomarkers, increasing accuracy and availability of transplanted kidneys. The study found that combining these biomarkers with the widely used Kidney Donor Profile Index significantly improves prediction of transplant success.
Researchers at Penn State have developed a new approach to diagnose sepsis-causing bacteria in blood infections, which can rapidly identify the specific pathogens and ideal antibiotics. This new approach, called STREAM, enables faster diagnosis and treatment, potentially reducing antibiotic resistance and improving patient outcomes.
A new study from Karolinska Institutet suggests that breast cancer classification may overlook important biological differences between patients that could affect treatment decisions. Women with tumours having low to moderate levels of estrogen receptors have poorer survival rates, highlighting the importance of precise classification.
Researchers at the Max Delbrück Center used proteomics and AI to identify a seven-protein signature in blood plasma that reliably indicates vasculitis remission. This biomarker could enable precise treatment with fewer side effects, improving patient outcomes.
UCSF's new center aims to train 1,000 health care providers annually and develop screening tools to identify eating disorders. The center will also serve as a national hub for eating disorders research, connecting investigators across institutions and disciplines.
A large population-based study found that emergency diagnoses are common across multiple conditions, including Parkinson’s disease and coronary heart disease, and are consistently associated with worse outcomes. The study suggests that emergency diagnosis is a common phenomenon across diverse diseases and is linked to higher mortality ...
A new blood test detects Alzheimer's disease using plasma amyloid-β seeding activity, achieving a diagnostic accuracy exceeding 90% in the validation cohort. The test uses real-time ultrasonic protein misfolding cyclic amplification technology, marking a critical transition in AD diagnosis.
USC researchers have developed custom, 3D-printed MRI sensors that provide clearer images of small organs in infants and children. The sensors, which can be customized to individual patients, are made in under 10 minutes and cost around $30.